SCHEMBL627250

SCHEMBL627250

CC(C)N(Cc1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.53
TSHR P16473 3/20 0.50
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47
SLC6A2 P23975 1/20 0.47
HTR2A P28223 1/20 0.47
SLC6A4 P31645 1/20 0.47
ADRA1A P35348 1/20 0.47
OPRK1 P41145 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KCNH2 Q12809 1/20 0.47
AOC3 Q16853 1/20 0.45
CYP2C19 P33261 1/20 0.44
SIGMAR1 Q99720 1/20 0.43
S1PR1 P21453 1/20 0.42
CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10473950 0.88 CYP2C19 (0.52) TAAR1TSHRCYP2C19CNR2
SCHEMBL11824331 0.88 CYP2C19 (0.61) TAAR1TSHRALDH1A1MEN1KMT2A
SCHEMBL28819131 0.87 TAAR1 (0.43) TAAR1TSHRALDH1A1MEN1KMT2A
SCHEMBL11669812 0.84 TAAR1 (0.54) TAAR1TSHRALDH1A1MEN1KMT2A
SCHEMBL9312140 0.83 TSHR (0.47) TSHRALDH1A1MEN1KMT2AADRA2B
SCHEMBL11690259 0.83 TSHR (0.47) TAAR1TSHRALDH1A1MEN1KMT2A
SCHEMBL10650506 0.83 TSHR (0.47) TAAR1TSHRALDH1A1MEN1KMT2A
SCHEMBL10690755 0.82 TSHR (0.50) TAAR1TSHRALDH1A1MEN1KMT2A
SCHEMBL27886896 0.82 SLC6A2 (0.61) TAAR1TSHRADRA2BADRA2CSLC6A2
SCHEMBL11670174 0.81 BCHE (0.52) ALDH1A1SLC6A2SLC6A3CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12110262-B2 Compound, core-shell dye, photosensitive resin composition including the same, and color filter SAMSUNG SDI CO., LTD. (KR) 2024-10-08 US disclosed
US-12077631-B2 Bulk polymerisation of polyoxazolidone BASF SE (DE) 2024-09-03 US disclosed
US-11945763-B2 Compound, core-shell dye, photosensitive resin composition including the same, and color filter SAMSUNG SDI CO., LTD. (KR) 2024-04-02 US disclosed
CN-112424253-B Bulk polymerization of polyoxazolidinones 巴斯夫欧洲公司 2024-02-27 CN disclosed
WO-2023215590-A2 ANTIDEGRADANT COMPOUNDS AND USES THEREOF FLEXSYS AMERICA L.P. (US) 2023-11-09 WO disclosed
CN-109715599-B Novel compound, core-shell dye, photosensitive resin composition containing the same, and color filter 三星SDI株式会社 2023-02-28 CN disclosed
US-20220388945-A1 COMPOUND, CORE-SHELL DYE, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME, AND COLOR FILTER SAMSUNG SDI CO LTD (KR) 2022-12-08 US disclosed
US-20220380297-A1 COMPOUND, CORE-SHELL DYE, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME, AND COLOR FILTER SAMSUNG SDI CO LTD (KR) 2022-12-01 US disclosed
EP-3824012-B1 BULK POLYMERISATION OF POLYOXAZOLIDONE BASF SE (DE) 2022-09-07 EP disclosed
US-11427529-B2 Compound, core-shell dye, photosensitive resin composition including the same, and color filter SAMSUNG SDI CO., LTD. (KR) 2022-08-30 US disclosed
WO-2005068404-A1 DISTILLATION OF IONIC LIQUIDS BASF AKTIENGESELLSCHAFT (DE) 2005-07-28 WO disclosed
US-20050020857-A1 Removal by salt formation BASF AKTIENGESELLSCHAFT (DE) 2005-01-27 US disclosed
EP-1472201-A2 METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS BASF AKTIENGESELLSCHAFT (DE) 2004-11-03 EP disclosed
WO-2003062171-A2 METHOD FOR THE SEPARATION OF ACIDS FROM CHEMICAL REACTION MIXTURES BY MEANS OF IONIC FLUIDS BASF AKTIENGESELLSCHAFT (DE) 2003-07-31 WO disclosed
EP-0433662-A2 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-06-26 EP disclosed
US-4958029-A Process for the production of isoindoline derivatives, novel intermediates and process for their production BANYU PHARMACEUTICAL CO., LTD. (JP) 1990-09-18 US disclosed
EP-0275064-A2 Process for the production of isoindoline derivatives, novel intermediates and process for their production Banyu Pharmaceutical Co., Ltd. (JP) 1988-07-20 EP disclosed
US-4048229-A ANTAGONIST ACTIVITY SMITHKLINE CORPORATION (US) 1977-09-13 US disclosed
US-3976694-A BETA-ADRENERGIC STIMULANT, BRONCHODILATOR SMITHKLINE CORPORATION (US) 1976-08-24 US disclosed
US-3961076-A BRONCHODILATORS SMITHKLINE CORPORATION (US) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11427529-B2 Compound, core-shell dye, photosensitive resin composition including the same, and color filter SUN2, PSMD9, PSMD7 TAAR1 3525/4885TSHR 4474/4885ALDH1A1 1502/4885
US-12110262-B2 Compound, core-shell dye, photosensitive resin composition including the same, and color filter SUN2, RBBP9, PSMD7 TAAR1 3367/4885TSHR 4403/4885ALDH1A1 1647/4885
US-20220380297-A1 COMPOUND, CORE-SHELL DYE, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME, AND COLOR FILTER SUN2, PSMD9, PSMD7 TAAR1 3525/4885TSHR 4474/4885ALDH1A1 1502/4885
US-20050020857-A1 Removal by salt formation PHOSPHO1, AASDHPPT, INPP5B TAAR1 1286/4885TSHR 1936/4885ALDH1A1 4228/4885
US-11945763-B2 Compound, core-shell dye, photosensitive resin composition including the same, and color filter SUN2, RBBP9, PSMD7 TAAR1 3367/4885TSHR 4403/4885ALDH1A1 1647/4885
US-20220388945-A1 COMPOUND, CORE-SHELL DYE, PHOTOSENSITIVE RESIN COMPOSITION INCLUDING THE SAME, AND COLOR FILTER SUN2, PSMD9, PSMD7 TAAR1 3525/4885TSHR 4474/4885ALDH1A1 1502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.